Sci Rep 2020: NO-mediated vasodilation
The Underground Wellness Trend the FDA Just Banned (BPC-157, TB-500, and the 2026 Controversy) Rejuv Feb 23 11 min read BPC-157: Miracle Healing or Dangerous Hype
A recent observational study found that, in a group of vaccinated, non-hospitalized patients, oral nirmatrelvir/ritonavir was not associated with reduced long COVID symptoms beyond 90 days post-infection [10]
Bioorg Med Chem 2018;26, 3925-3938, doi:10.1016/j.bmc.2018.06.013
Applications of BPC-157 BPC-157s versatility makes it a valuable option for a wide range of conditions: Injury Recovery: Particularly beneficial for athletes or individuals recovering from musculoskeletal injuries such as sprains, strains, or ligament tears